Evidence map›Paper›PMID 26038523›Full record

ReviewCirculation. Cardiovascular quality and outcomes2015

Building the Case for Clopidogrel as a World Health Organization Essential Medicine.

Amisha Patel, Mahesh Vidula, Sunny P Kishore, Rajesh Vedanthan, Mark D Huffman

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Circulation. Cardiovascular quality and outcomes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. The Role of Clopidogrel in 2020: A Reappraisal.Cardiovascular therapeutics · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amisha PatelFrom the Departments of Preventive Medicine and Medicine-Cardiology (A.P., M.D.H.), Northwestern University Feinberg School of Medicine, Chicago, IL (M.V.); Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (S.P.K.); Young Professionals Chronic Disease Network, Boston, MA (S.P.K.); and Department of Medicine-Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (R.V.). amisha.patel@northwestern.edu.
Mahesh VidulaFrom the Departments of Preventive Medicine and Medicine-Cardiology (A.P., M.D.H.), Northwestern University Feinberg School of Medicine, Chicago, IL (M.V.); Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (S.P.K.); Young Professionals Chronic Disease Network, Boston, MA (S.P.K.); and Department of Medicine-Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (R.V.).
Sunny P KishoreFrom the Departments of Preventive Medicine and Medicine-Cardiology (A.P., M.D.H.), Northwestern University Feinberg School of Medicine, Chicago, IL (M.V.); Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (S.P.K.); Young Professionals Chronic Disease Network, Boston, MA (S.P.K.); and Department of Medicine-Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (R.V.).
Rajesh VedanthanFrom the Departments of Preventive Medicine and Medicine-Cardiology (A.P., M.D.H.), Northwestern University Feinberg School of Medicine, Chicago, IL (M.V.); Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (S.P.K.); Young Professionals Chronic Disease Network, Boston, MA (S.P.K.); and Department of Medicine-Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (R.V.).
Mark D HuffmanFrom the Departments of Preventive Medicine and Medicine-Cardiology (A.P., M.D.H.), Northwestern University Feinberg School of Medicine, Chicago, IL (M.V.); Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (S.P.K.); Young Professionals Chronic Disease Network, Boston, MA (S.P.K.); and Department of Medicine-Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (R.V.).

Funding

Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMCR24TW007988 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2007 to 2011
$27.6M
Acute Coronary Syndrome Quality Improvement in Kerala (ACS QUIK)R00HL107749 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HUFFMAN, MARK D · 2014 to 2016
$744k
Nurse Management of Hypertension in Rural Western KenyaK01TW009218 · FIC · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI VEDANTHAN, RAJESH · 2011 to 2015
$638k
FIC NIH HHS K01 TW009218FIC NIH HHS K01 TW 009218-04FIC NIH HHS R24 TW007988NHLBI NIH HHS 1 R00 HL107749NHLBI NIH HHS R00 HL107749
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Health PolicyPublic HealthWorld Health OrganizationCardiovascular DiseasesClopidogrelDrugs, EssentialDrug UtilizationHumansPlatelet Aggregation InhibitorsTiclopidineClopidogrelDrugs, EssentialPlatelet Aggregation InhibitorsTiclopidineclopidogreldrugsessentialWorld Health Organization

Identifiers

PMID26038523
PMCPMC4512846

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.